CRDF

Cardiff Oncology, Inc. Common Stock US Stock
$2.2
Open: $2.26 High: $2.38 Low: $2.03 Close: $2.145
Range: 2022-06-27 - 2022-06-28
Volume:637,552
Market: Open
CRDF
Cardiff Oncology, Inc. Common Stock 11055 FLINTKOTE AVENUE https://www.cardiffoncology.com
Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias.
  • CEO:
  • Employees: 23
  • Sector:
  • Industry:
Latest Stocks Posts
Card image
Card image
Card image
CRDF News
Latest news about the CRDF